An experimental arthritis in rats: Dorsal horn aspartate and glutamate increases

doi:10.1016/0304-3940(92)90006-S

Neuroscience Letters

Volume 145, Issue 2, 12 October 1992, Pages 141-144

https://doi.org/10.1016/0304-3940(92)90006-S Get rights and content

Abstract

Amino acid release in the dorsal horn of awake rats was examined by microdialysis during the development of arthritis induced by injection of 3% kaolin and 3% carrageenan into the knee joint. The following amino acids were measured by HPLC at baseline and for the first 8 h of arthritis: Asp, Glu, Asn, Gln, Ser, Gly and Tau. An initial increase in all amino acids examined was observed on injection of the knee joint with kaolin and carrageenan. Subsequently, there was a peak increase in Asp (184%), Glu (188%) and Gln (146%) during a prolonged release phase which began at 3.5 h and persisted at least 8 h. While Asn showed no changes from baseline, extracellular fluid concentrations of Ser, Gly and Tau were variable. This data indicates that the induction of arthritis is accompanied by an increased release of excitatory amino acids Asp and Glu which may be important in the generation of acute arthritis.

References (20)

R.E. Coggeshall et al.
Discharge characteristics of fine medial articular afferents at rest and during passive movements of inflamed knee joints
Brain Res.
(1983)
P.M. Dougherty et al.
Neural changes in acute arthritis in monkeys. I. Parallel enhancement of responses of spinothalamic tract neurons to mechanical stimuli and excitatory amino acids
Brain Res. Rev.
(1992)
I. Kangrga et al.
The effects of substance P and calcitonin gene-related peptide on the efflux of endogenous glutamate and aspartate from the rat spinal dorsal horn in vitro
Neurosci. Lett.
(1990)
K. Murase et al.
Excitatory and inhibitory amino acids and peptide-induced responses in acutely isolated rat spinal dorsal horn neurons
Neurosci. Lett.
(1989)
T.E. Salt
Modulation of NMDA receptor-mediated responses by glycine and d-serine in the rat thalamus in vivo
Brain Res.
(1989)
H.-G. Schaible et al.
Release of immunoreactive substance P in the spinal cord during development of acute arthritis in the knee joint of the cat: a study with antibody microprobes
Brain Res.
(1990)
K.A. Sluka et al.
Neural changes in acute arthritis in monkeys. III. Changes in substance P, calcitonin gene-related peptide and glutamate in the dorsal horn of the spinal cord
Brain Res. Rev.
(1992)
D.H. Smullin et al.
Interaction between substance P, calcitonin gene-related peptide, taurine and excitatory amino acids in the spinal cord
Pain
(1990)
L.S. Sorkin et al.
Microdialysis recovery of serotonin released in spinal cord dorsal horn
J. Neurosci. Methods
(1988)
L.S. Sorkin et al.
Neural changes in acute arthritis in monkeys. IV. Time-course of amino acid release into the lumbar dorsal horn
Brain Res. Rev.
(1992)

There are more references available in the full text version of this article.

Cited by (121)

The cornucopia of central disinhibition pain – An evaluation of past and novel concepts
2020, Neurobiology of Disease
Citation Excerpt :
At a more upstream molecular basis, glutamate is an important excitatory neurotransmitter which promotes synaptic transmission of nociception. At spinal cord level, acute or persistent pain induces a release of glutamate via primary afferent neurons into the dorsal horn (Sluka and Westlund, 1992; Sorkin et al., 1992). Moreover, the expression of glutamate receptors especially in microglia cells contributes to neuroinflammation and central sensitization (Basbaum et al., 2009; Ji et al., 2013).
Central disinhibition (CD), as applied to pain, decreases thresholds of endogenous systems. This provokes onset of spontaneous or evoked pain in an individual beyond the ability of the nervous system to inhibit pain resulting from a disease or tissue damage. The original CD concept as proposed by Craig entails a shift from the lateral pain pathway (i.e. discriminative pain processing) towards the medial pain pathway (i.e. emotional pain processing), within an otherwise neurophysiological intact environment. In this review, the original CD concept as proposed by Craig is extended by the primary “nociceptive pathway damage – CD” concept and the secondary “central pathway set point – CD”. Thereby, the original concept may be transferred into anatomical and psychological non-functional conditions. We provide examples for either primary or secondary CD concepts within different clinical etiologies as well as present surrogate models, which directly mimic the underlying pathophysiology (A-fiber block) or modulate the CD pathway excitability (thermal grill). The thermal grill has especially shown promising advancements, which may be useful to examine CD pathway activation in the future. Therefore, within this topical review, a systematic review on the thermal grill illusion is intended to stimulate future research. Finally, the authors review different mechanism-based treatment approaches to combat CD pain.
Pain System
2015, The Rat Nervous System: Fourth Edition
The pain system is the set of neural pathways responsible for mediating the sensations interpreted as pain. Sensory-discriminative aspects of pain originating from the body surface include coding for the precise quality, intensity, duration, and location of the sensory input. Pain arising from visceral organs and other deep structures of the body is usually poorly localized and has a different, dull aching quality. Neurons that signal the sensory-discriminative components of pain sensation encode these aspects of painful stimuli in a manner generally similar to that used by other sensory systems, such as the visual and auditory systems. However, pain more powerfully engages mechanisms of attention and arousal in limbic regions of the brain than is generally the case for vision and audition. The sense of pain is more often accompanied by strong motivational-affective responses, including emotional reactions (suffering, anxiety, depression), somatic and autonomic reflexes, and endocrine changes. This is especially true for visceral pain. The neural pathways that mediate the motivational-affective components of pain overlap to some extent those involved in pain sensation, but also include additional neural structures and pathways. A better understanding of many complex mechanisms and circuitries underlying sensory dysfunction gained through the study of animal models has translated into existing successful therapies. Focus on the neuroplasticity and dysfunctional mechanisms induced in chronic pain models is leading to the development of better future therapeutics.
Anti-inflammatory effect of triterpene 3β, 6β, 16β-trihydroxylup-20(29)-ene obtained from Combretum leprosum Mart & Eich in mice
2012, Journal of Ethnopharmacology
Citation Excerpt :
Taking the literature data and the results presented here into account, the antinociceptive and anti-inflammatory actions of Combretum leprosum-derived TTHL in the acetic acid abdominal constriction test might be due to an inhibition in the release of endogenous inflammatory mediators by resident peritoneal cells. There are evidences showing that inflammation and/or tissue damage can induce the release of glutamate from primary afferents, enhancing the activation of excitatory amino acid receptors in the peripheral tissue (Carlton, 2001; Hoffman and Miller, 2010; Miller et al., 2011; Sluka and Westlund, 1992). The activation of glutamate NMDA receptors causes the secretion of inflammatory mediators, i.e., TNF-α and IL-1β, that in turn can sensitize peripheral nerve endings and activate the immune response (Kane et al., 2005; McNearney et al., 2010; Sweeney and Firestein, 2004; Zelenka et al., 2005).
The 3β, 6β, 16β-trihydroxylup-20(29)-ene (TTHL) is a pentacyclic triterpene obtained from a medicinal plant named Combretum leprosum. In folk medicine, this plant is used to treat several diseases associated with inflammation and pain. We previously demonstrated that TTHL presents a significant antinociceptive effect, suggesting the involvement of the glutamatergic system.
This study was designed to investigate the effect of TTHL on nociception and vascular permeability induced by acetic acid. We also evaluated the effect of TTHL on carrageenan-induced peritonitis and the levels of cytokines (interleukin 1-β [IL-1β], tumor necrosis factor α [TNF-α] and interleukin 10 [IL-10]) on peritoneal fluid.
TTHL was administered orally by intra-gastric gavage (i.g.) 60 min prior to experimentation. Abdominal contractions and vascular permeability were induced by an intraperitoneal (i.p.) injection of acetic acid (0.6%). We also investigated whether TTHL decreases carrageenan-induced peritonitis (750 μg/cavity) by measuring leukocyte migration and vascular permeability. In addition, we evaluated the effects of TTHL on TNF-α, IL-1β and IL-10 release induced by carrageenan on peritoneal fluid. The levels of these cytokines were measured by ELISA.
TTHL (0.01–10 mg/kg) administered by intra-gastric (i.g.) gavage inhibited (69±3%) acetic acid-induced abdominal constrictions, with an ID₅₀ of 0.15 (0.03–0.8) mg/kg. TTHL (10 mg/kg) also reduced the leukocyte infiltration induced by acetic acid, with an inhibition of 59±9 but had no effect on abdominal vascular permeability. In addition, indomethacin (10 mg/kg, i.p.) reduced the nociceptive behavior (92±1%), total leukocyte migration (29±3%) and capillary permeability (71±3%) induced by acetic acid. While the glucocorticoid dexamethasone (2 mg/kg, s.c.) reduced partially but significantly the nociception (31±1%), besides to promote a marked reduction on total leukocyte migration (60±2%) to the peritoneal cavity caused by acetic acid. In a model of peritonitis induced by carrageenan, TTHL also reduced total leukocyte migration, mainly neutrophils (inhibition of 84±3% and 85±2% at 30 mg/kg and 100 mg/kg, respectively). Likewise, dexamethasone (0.5 mg/kg, i.p.) resulted in an inhibition of 93±3%. Nevertheless, carrageenan-induced abdominal vascular permeability was reduced by dexamethasone but was not altered by TTHL. Furthermore, dexamethasone and TTHL significantly reduced the TNF-α and IL-1β levels in peritoneal fluid, whereas the IL-10 levels were unchanged.
Altogether, our data confirm the antinociceptive effect of TTHL and demonstrate its effect in inflammatory animal models, providing novel data about this compound, which could be useful as an anti-inflammatory drug.
Imbalance between excitatory and inhibitory amino acids at spinal level is associated with maintenance of persistent pain-related behaviors
2009, Pharmacological Research
Although the postsynaptic events responsible for development of pathological pain have been intensively studied, the relative contribution of presynaptic neurotransmitters to the whole process remains less elucidated. In the present investigation, we sought to measure temporal changes in spinal release of both excitatory amino acids (EAAs, glutamate and aspartate) and inhibitory amino acids (IAAs, glycine, γ-aminobutyric acid and taurine) in response to peripheral inflammatory pain state. The results showed that following peripheral chemical insult induced by subcutaneous bee venom (BV) injection, there was an initial, parallel increase in spinal release of both EAAs and IAAs, however, the balance between them was gradually disrupted when pain persisted longer, with EAAs remaining at higher level but IAAs at a level below the baseline. Moreover, the EAAs–IAAs imbalance at the spinal level was dependent upon the ongoing activity from the peripheral injury site. Intrathecal blockade of ionotropic (NMDA and non-NMDA) and metabotropic (mGluRI, II, III) glutamate receptors, respectively, resulted in a differential inhibition of BV-induced different types of pain (persistent nociception vs. hyperalgesia, or thermal vs. mechanical hyperalgesia), implicating that spinal antagonism of any specific glutamate receptor subtype fails to block all types of pain-related behaviors. This result provides a new line of evidence emphasizing an importance of restoration of EAAs–IAAs balance at the spinal level to prevent persistence or chronicity of pain.
Surgical incision can alter capsaicin-induced central sensitization in rat brainstem nociceptive neurons
2008, Neuroscience
Citation Excerpt :
However, the activation of endogenous inhibitory mechanisms by the intense cumulative incision and capsaicin-evoked noxious stimulation of TMJ-responsive nociceptive neurons most likely accounts for the present findings in these neurons. It has been proposed that the large increase in EAAs in the spinal cord as a result of noxious stimulation is followed (Sorkin et al., 1992) or accompanied (Sluka and Westlund, 1992) by increased concentrations of inhibitory amino acids (IAAs), which may reflect activation of endogenous inhibitory responses, consistent with findings in the trigeminal system (Yu et al., 1994; Hu et al., 1997). Increased concentrations of the IAA serine have been shown to parallel increased concentrations of the EAAs glutamate and aspartate in the spinal cord for 10–30 min after plantar incision (Zahn et al., 2002).
Surgical trauma can affect spinal neuronal excitability, but there have been no studies of the effects of surgical cutaneous injury on central nociceptive processing of deep afferent inputs evoked by noxious stimuli such as capsaicin. Thus our aim was to test the effect of surgical cutaneous incision in influencing central sensitization induced by capsaicin injection into the temporomandibular joint (TMJ). The activity of single nociceptive neurons activated by noxious mechanical stimulation of the TMJ was recorded in the trigeminal subnucleus caudalis/upper cervical cord of halothane-anesthetized rats. The cutaneous mechanoreceptive field (RF), cutaneous mechanical activation threshold (MAT) and TMJ MAT of neurons before and after both surgical cutaneous incision alone and capsaicin injection were compared with results of incision and lidocaine pretreatment of the facial skin overlying the TMJ and capsaicin injection into the TMJ. Incision itself induced a barrage of neuronal spikes and excitability increases reflecting central sensitization (cutaneous RF expansion, cutaneous MAT reduction) in most neurons tested whereas lidocaine pretreatment significantly attenuated the barrage and central sensitization. Capsaicin injection into the TMJ induced cutaneous RF expansion, cutaneous MAT reduction and TMJ MAT reduction following lidocaine pretreatment of the cutaneous incision site whereas capsaicin injection following incision alone not only failed to induce further central sensitization but also decreased the existing incision-induced central sensitization (no cutaneous RF expansion, increased cutaneous MAT and TMJ MAT) in most neurons tested. These findings suggest that central sensitization induced by capsaicin alone or by cutaneous incision alone can readily occur in TMJ-responsive nociceptive neurons and that following incision-induced excitability increases, capsaicin may result in a temporary suppression of nociceptive neuronal changes reflecting central sensitization.
The peripheral role of group I metabotropic glutamate receptors on nociceptive behaviors in rats with knee joint inflammation
2007, Neuroscience Letters
We examined whether the mGluR1 and mGluR5 were involved in development and maintenance of behavioral signs of non-evoked pain and secondary mechanical hyperalgesia induced by knee joint inflammation. Selective mGluR1 antagonist, (RS)-1-aminoindan-1,5-dicarboxylic acid (AIDA: 50, 100, 200 μM/25 μl, n = 10 per group) and selective mGluR5 antagonist, 2-methyl-6-(phenylethynyl)-pyridine (MPEP: 50, 100, 200 nM/25 μl, n = 10 per group) was intra-articularly (i.a.) injected 30 min before and 4 h after carrageenan injection and behavioral tests were conducted. In the pre-treatment, only a higher dose (200 nM) of MPEP significantly prevented the magnitude of weight load reduction, whereas AIDA (200 μM) and MEPE (50, 100 and 200 nM) significantly reduced the development of mechanical hyperalgesia compared to saline treated group. In the post-treatment, AIDA (200 μM) and MPEP at 100 and 200 nM partially reversed the reduction of weight load induced by carrageenan. MPEP significantly increased the withdrawal threshold to mechanical stimulation in a dose-dependent manner, whereas AIDA had significantly reversed the decreased the paw withdrawal threshold only at 200 μM. The present study demonstrated that i.a. MPEP, selective mGluR5 antagonist is more effective than selective mGluR1 antagonist, AIDA on non-evoked pain as well as mechanical hyperalgesia in both induction and maintenance phase in knee joint inflammation. It is suggested that peripheral mGlu5 receptors play a more prominent role in inflammatory pain including evoked and spontaneous pain. Thus, selective mGluR5 antagonist could be effective therapeutic tools in clinical setting.

View all citing articles on Scopus

View full text

An experimental arthritis in rats: Dorsal horn aspartate and glutamate increases

Abstract

Brain Res.

Brain Res. Rev.

Neurosci. Lett.

Neurosci. Lett.

Brain Res.

Brain Res.

Brain Res. Rev.

Pain

J. Neurosci. Methods

Brain Res. Rev.